This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Bt Group PLC | 137.9 | 3.1% |
| BP PLC | 531.6 | 3.0% |
| Persimmon PLC | 1,497.0 | 2.2% |
| Hiscox LTD | 1,150.5 | 2.2% |
| Halma PLC | 2,308.0 | 1.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Smith (Ds) PLC | 350.9 | -3.8% |
| Smurfit Kappa Group PLC | 3,361.0 | -3.6% |
| Rs Group PLC | 993.5 | -1.8% |
| Mondi PLC | 1,531.0 | -1.6% |
| Haleon PLC | 329.1 | -1.3% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,885 | 0.3% | 3.2% |
| DOW JONES INDUS. AVG | 33,949 | -0.6% | -5.1% |
| DAX INDEX | 15,412 | 0.6% | -0.5% |
| NIKKEI 225 | 27,584 | -0.1% | 0.0% |
| S&P/ASX 200 INDEX | 7,490 | -0.5% | 3.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 78.50 | 0.04% |
| Brent Crude (ICE) | USD/bbl. | 85.17 | 0.09% |
| Gold Spot | USD/t oz. | 1,881 | 0.3% |
| Copper (Comex) | USd/lb. | 408 | 1.1% |
Click graph to enlarge
The UK 100 called to open +23 points at 7908. The UK 100 looks set to open higher again today, after setting new intraday highs yesterday, investors will be looking to see if these will again be tested? It was a mixed session in Asia today, the Nikkei index closed down 0.1%. In China, the Shanghai Composite was up 1.1%, while the Hang Seng index in Hong Kong was 1.2%. The S&P/ASX 200 in Sydney closed down 0.5%. On Wall Street yesterday, The Dow Jones closed 208 points lower or 0.6%, at 33,949, the Nasdaq slid 203 points or 1.7%, to 11,911 and the S&P lost 46 points or 1.1%, to 4,118. The small-cap focused Russell 2000 dropped 28 points, to 1,995.
AstraZeneca posted Q4 revenue just shy of analyst estimates, with slightly lower-than-expected sales of its best-selling oncology and rare blood disorder drugs. They reported an adjusted profit of 1.38 cents per share on sales of about $11.2bn.
Bellway reports H1 home completions of 5,695 flat on 5,694 YoY, with the selling price up 1.6% to £316,900. Their H1 reservation rate is down 32% amid weaker private demand. They have a forward order book of 5,108 homes, down from 6,628 YoY.
British American Tobacco are in talks to complete the sales of their Russian and Belarusian businesses in 2023. Their FY new categories revenue +37% to £2,813m as they announce a FY dividend per share of 230.9p. They see 2023 strong new category revenue growth with further improvement in category contribution alongside incremental investment.
Redrow have withdrawn their guidance for 2024, due to change in market conditions. They have maintained their interim dividend at 10p. They expect their 2023 revenue to be £2.05bn.
Unilever reported quarterly underlying sales growth above expectations, helped by higher prices for its detergents, soaps and packaged foods. They expect cost inflation to continue in 2023, forecasting net material inflation in the first half of around 1.5bn euros.
Watches of Switzerland Q3 revenue rises by 17% as their reiterate their FY guidance.
RPT/HSBC Downgrades Hiscox to Hold from Buy (3 Buys / 10 Holds / 0 Sells)
UK
Bellway
British American Tobacco
Compass Group
Crest Nicholson*
PZ Cussons
Pershing Square Holdings
Unilever
AstraZeneca
Redrow
Watches of Switzerland
US
AbbVie
PepsiCo
Philip Morris International
PayPal Holdings
UK
Beazley
EU leaders summit
European Commission releases Economic Growth Forecasts
US Initial Jobless Claims
UK 100 companies going ex-dividend on 9th February 2023:
None
UK 250 companies going ex-dividend on 9th February 2023:
Virgin Money UK
Greencoat UK Wind
Henderson Smaller Cos Inv Tst
GCP Infrastructure Investments
Aberforth Smaller Companies Trust
Octopus Renewables Infrastructure Trust
Impax Environmental Markets
UK Commercial Property REIT
Balanced Commercial Property Trust
Target Healthcare REIT
Renewables Infrastructure Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.